Lack of effect on adult and adolescent hypothalamic-pituitary-adrenal axis function with use of fluticasone furoate nasal spray

Annals of Allergy, Asthma and Immunology

Volumn 100, Issue 5, 2008, Pages 490-496

  Patel, Deepen ^a   Ratner, Paul ^b   Clements, Diane ^c   Wu, Wei ^c   Faris, Melissa ^c   Philpot, Edward ^c  

^a Allied Research International   (Canada)

^b Sylvana Research Associates   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6BETA HYDROXYHYDROCORTISONE; FLUTICASONE FUROATE; HYDROCORTISONE; NOSE SPRAY; PLACEBO; PREDNISONE;

ADOLESCENT; ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; CANADA; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG FATALITY; DRUG SAFETY; DRUG TOLERABILITY; ENDOCRINE DISEASE; EPISTAXIS; FEMALE; HEADACHE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTPATIENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; TREATMENT DURATION; UNITED STATES; URINARY EXCRETION;

EID: 43449116642     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60476-0     Document Type: Article

References (31)

1. RA Settipane Demographics and epidemiology of allergic and nonallergic rhinitis Allergy Asthma Proc 22 2001 185 189
2. V Bauchau SR Durham Prevalence and rate of diagnosis of allergic rhinitis in Europe Eur Respir J 24 2004 758 764
3. WF Schoenwetter L Dupclay Jr S Appajosyula MF Botteman CL Pashos Economic impact and quality-of-life burden of allergic rhinitis Curr Med Res Opin 20 2004 305 317
4. S Walker S Khan-Wasti M Fletcher Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study J Allergy Clin Immunol 120 2007 381 387
5. A Long C McFadden D DeVine Management of Allergic and Nonallergic Rhinitis Evidence Report/Technology Assessment No. 54 2002 Agency for Healthcare Research and Quality, US Department of Health and Human Services Rockville, MD
6. Task Force on Allergic Disorders The Allergy Report 1 2000 American Academy of Allergy, Asthma and Immunology Milwaukee, WI
7. J Bousquet P van Cauwenberge N Ait Khaled Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN) Allergy 61 2006 1086 1096
8. MS Benninger N Ahmad BF Marple The safety of intranasal steroids Otolaryngol Head Neck Surg 129 2003 739 750
9. BG Martin PH Ratner FC Hampel Optimal dose selection of fluticasone furoate nasal spray for the treatment of seasonal allergic rhinitis in adults and adolescents Allergy Asthma Proc 28 2007 216 225
10. GP Chrousos AG Harris Hypothalamic-pituitary-adrenal axis suppression and inhaled corticosteroid therapy, 1: general principles Neuroimmunomodulation 5 1998 277 287
11. DB Allen Systemic effects of intranasal steroids: an endocrinologist's perspective J Allergy Clin Immunol 106 2000 S179 S190
12. RA Settipane P Lieberman Update on nonallergic rhinitis Ann Allergy Asthma Immunol 86 2001 494 507
13. C Bachert KF Lukat B Lange Effect of intranasal fluticasone propionate and triamcinolone acetonide on basal and dynamic measures of hypothalamic-pituitary-adrenal-axis activity in healthy volunteers Clin Exp Allergy 34 2004 85 90
14. RA Nathan EA Bronsky P Fireman Once daily fluticasone propionate aqueous nasal spray is an effective treatment for seasonal allergic rhinitis Ann Allergy 67 1991 332 338
15. R Vargas RJ Dockhorn SR Findlay Effect of fluticasone propionate aqueous nasal spray versus oral prednisone on the hypothalamic-pituitary-adrenal axis J Allergy Clin Immunol 102 1998 191 197
16. KK Sheth CK Cook EE Philpot Concurrent use of intranasal and orally inhaled fluticasone propionate does not affect hypothalamic-pituitary-adrenal-axis function Allergy Asthma Proc 25 2004 115 120
17. R Nave MA Wingertzahn S Brookman S Kaida T Matsunaga Safety, tolerability, and exposure of ciclesonide nasal spray in healthy and asymptomatic subjects with seasonal allergic rhinitis J Clin Pharmacol 46 2006 461 467
18. N Lindqvist VH Balle P Karma Long-term safety and efficacy of budesonide nasal aerosol in perennial rhinitis: a 12-month multicentre study Allergy 41 1986 179 186
19. MJ Welch E Bronsky S Findlay Long-term safety of triamcinolone acetonide nasal aerosol for the treatment of perennial allergic rhinitis Clin Ther 16 1994 253 262
20. AS Nayak MH Ellis GN Gross The effects of triamcinolone acetonide aqueous nasal spray on adrenocortical function in children with allergic rhinitis J Allergy Clin Immunol 101 1998 157 162
21. DP Skoner GS Rachelefsky EO Meltzer Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate Pediatrics 105 2000 E23
22. PT Daley-Yates DH Richards Relationship between systemic corticosteroid exposure and growth velocity: development and validation of a pharmacokinetic/pharmacodynamic model Clin Ther 26 2004 1905 1919
23. MS Dykewicz S Fineman DP Skoner Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology Ann Allergy Asthma Immunol 81 1998 478 518
24. WE Berger JW Godfrey AL Slater Intranasal corticosteroids: the development of a drug delivery device for fluticasone furoate as a potential step toward improved compliance Expert Opin Drug Deliv 4 2007 689 701
25. A Allen G Down A Newland Absolute bioavailability of intranasal fluticasone furoate in healthy subjects Clin Ther 29 2007 1415 1420
26. AL Boner Effects of intranasal corticosteroids on the hypothalamic-pituitary-adrenal axis in children J Allergy Clin Immunol 108 2001 S32 S39
27. M Hubner G Hochhaus H Derendorf Comparative pharmacology, bioavailability, pharmacokinetics, and pharmacodynamics of inhaled glucocorticosteroids Immunol Allergy Clin North Am 25 2005 469 488
28. T Gulliver N Eid Effects of glucocorticoids on the hypothalamic-pituitary-adrenal axis in children and adults Immunol Allergy Clin North Am 25 2005 541 555
29. L Agertoft OD Wolthers G Fuglsang S Pedersen Nasal powder administration of budesonide for seasonal rhinitis in children and adolescents Pediatr Allergy Immunol 4 1993 152 156
30. CM Kokron AS Castro D Sole CK Naspitz Lysine-vasopressin in the evaluation of the hypothalamic-pituitary-adrenal axis in children with allergic rhinitis treated with intranasal beclomethasone dipropionate or oral prednisone J Investig Allergol Clin Immunol 7 1997 51 56
31. A Rosenblut PG Bardin B Muller Long-term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis Allergy 62 2007 1071 1077